Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rifaximin for Preventing Recurrence of Retrograde Biliary Tract Infection
NCT07895433Phase 4Not yet recruiting
- Sponsor
- Ruijin Hospital
- Start
- Oct 2026
- Primary completion
- Oct 2027
01
Overview
A Phase 4 trial of rifaximin in ascending cholangitis (AC), sponsored by Ruijin Hospital. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
rifaximin
03
Conditions
ascending cholangitis (AC)
Beyond the preview
Go deeper on NCT07895433.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07895433.